Molecular studies of intra-tumor heterogeneity (ITH) are revealing a large amount of DNA-based variation in many individual tumors. In a recent publication by Yates and colleagues, the ITH of breast tumors was examined and shown to have important implications for the development of resistant disease, metastasis, and clinical sequencing efforts
Cancer progression in humans is difficult to infer because we do not routinely sample patients at mu...
Background: The advent of rapid and inexpensive sequencing technology allows scientists to decipher ...
There is burgeoning evidence to suggest that tumor evolution follows the laws of Darwinian evolution...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Increasing evidence supports the existence of intratumor heterogeneity (ITH) in many cancer types, w...
Aim: Present cancer hypotheses are almost all based on the concept that accumulation of specific dri...
In recent years it has become clear that cancer cells within a single tumor can display striking mor...
Intratumor genetic heterogeneity (ITH) is the main obstacle to effective cancer treatment and a majo...
Developments in genomic techniques have provided insight into the remarkable genetic complexity of m...
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
In this issue of Cancer Cell, Snuderl and coworkers demonstrate intratumoral genetic heterogeneity i...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Intratumoral heterogeneity (ITH) refers to a subclonal genetic diversity observed within a tumor. IT...
Extensive intratumoral heterogeneity (ITH) is believed to contribute to therapeutic failure and tumo...
Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We used the...
Cancer progression in humans is difficult to infer because we do not routinely sample patients at mu...
Background: The advent of rapid and inexpensive sequencing technology allows scientists to decipher ...
There is burgeoning evidence to suggest that tumor evolution follows the laws of Darwinian evolution...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Increasing evidence supports the existence of intratumor heterogeneity (ITH) in many cancer types, w...
Aim: Present cancer hypotheses are almost all based on the concept that accumulation of specific dri...
In recent years it has become clear that cancer cells within a single tumor can display striking mor...
Intratumor genetic heterogeneity (ITH) is the main obstacle to effective cancer treatment and a majo...
Developments in genomic techniques have provided insight into the remarkable genetic complexity of m...
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
In this issue of Cancer Cell, Snuderl and coworkers demonstrate intratumoral genetic heterogeneity i...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Intratumoral heterogeneity (ITH) refers to a subclonal genetic diversity observed within a tumor. IT...
Extensive intratumoral heterogeneity (ITH) is believed to contribute to therapeutic failure and tumo...
Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We used the...
Cancer progression in humans is difficult to infer because we do not routinely sample patients at mu...
Background: The advent of rapid and inexpensive sequencing technology allows scientists to decipher ...
There is burgeoning evidence to suggest that tumor evolution follows the laws of Darwinian evolution...